Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[What's new liquid biopsy-PIK3CA testing in breast cancer].

Der Pathologe - 1 Dec 2020

Vollbrecht Claudia

Abstract excerpt

The impact of liquid biopsies on the analysis of molecular alterations of circulating tumor DNA (ctDNA) has recently increased. PIK3CA is one of the most frequently mutated genes in breast cancer and the expected approval of targeted PIK3CA therapy based on the results of the SOLAR1 trial is likely to lead to the use of liquid biopsies as another promising testing strategy in breast cancer patients who can...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liquid Biopsy

Share to Mutation

Source

Identifiers

PMID: 33263809
DOI: 10.1007/s00292-020-00868-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[What's new liquid biopsy-PIK3CA testing in breast cancer].PMID 33263809Read ↗

Liquid Biopsy in Breast Cancer: A Focused Review.Semantic proximity Read ↗

Clinical utility of liquid biopsy in breast cancer: A systematic review.Semantic proximity Read ↗

Use of Liquid Biopsy to Detect PIK3CA Mutation in Metastatic Breast Cancer.Semantic proximity Read ↗

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.Semantic proximity Read ↗

[Current situation and prospect of breast cancer liquid biopsy].Semantic proximity Read ↗

The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.Semantic proximity Read ↗

Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.Semantic proximity Read ↗

The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.Semantic proximity Read ↗

[Clinically relevant molecular pathological diagnostics in breast cancer].Semantic proximity Read ↗

Untitled literature recordSemantic proximity Read ↗

Liquid biopsy enters the clinic - implementation issues and future challenges.Semantic proximity Read ↗

Update on the types and usage of liquid biopsies in the clinical setting: a systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.